Michael Aven

This inventor holds 25 USPTO granted patents and 7 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Boehringer Ingelheim Vetmedica Gmbh, Basf Aktiengesellschaft, American Cyanamid Company. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Aven. Retrieved from https://idiyas.com/inventor/michael-aven

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 7)

% Patents Active = 92.0

CIPO Patents = 6

EPO Patents = 10 (Patent Applications = 12)

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 103(Granted Patents)

Location History:

Mainz, DE (2000 - 2023)
Ingelheim am Rhein, DE (2018 - 2023)

Company Filing History:

11 out of 317

Boehringer Ingelheim Vetmedica Gmbh

patents

8 out of 10,816

Basf Aktiengesellschaft

patents

2 out of 3,580

American Cyanamid Company

5. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

Pharmaceutical Composition

Ciclesonide

Inhaler

Muscarinic Antagonists

Crop Protection

Fungicidal Formulation

Cyclodextrin Derivatives

Aqueous Suspension

Emulsifiable Concentrate

Carotenoid Biosynthesis

Triazolopyrimidines

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357696 - Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition (2025-07-15),

2. 11819549 - Pharmaceutical formulation comprising ciclesonide (2023-11-21),

3. 11679212 - Inhaler (2023-06-20),

4. 11185590 - Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition (2021-11-30),

5. 10925964 - Pharmaceutical formulation comprising ciclesonide (2021-02-23),

6. 10682345 - Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses (2020-06-16),

7. 10603451 - Container for an inhaler (2020-03-31),

8. 10441597 - Ciclesonide for the treatment of airway disease in horses (2019-10-15),

9. 10342789 - Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses (2019-07-09),

10. 10258634 - Ciclesonide for the treatment of airway disease in horses (2019-04-16),

11. 10071162 - Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition (2018-09-11),

12. 10046124 - Inhaler (2018-08-14),

13. 9918995 - Ciclesonide for the treatment of airway disease in horses (2018-03-20),

14. 9474747 - Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses (2016-10-25),

15. 7176209 - Fungicidal formulation (2007-02-13),

Title: The Innovative Journey of Michael Aven

Introduction: Michael Aven, a visionary inventor hailing from Mainz, Germany, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Michael Aven's latest patents include a revolutionary smart home automation system that integrates artificial intelligence for enhanced efficiency and a sustainable energy solution that harnesses solar power in urban environments.

Career Highlights: Throughout his illustrious career, Michael Aven has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His inventions have not only improved the quality of life for many but have also paved the way for future advancements in the industry.

Collaborations: Michael Aven has collaborated with leading tech companies and research institutions to further develop his inventions and bring them to the market. His partnerships have been instrumental in turning his ideas into reality and making a lasting impact on the world of technology.

Conclusion: In conclusion, Michael Aven's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire and shape the future of technology, making him a true pioneer in his field.

Profile summary based on public USPTO records.